PEN News and Press, Penumbra Inc. From 10/06/22

Penumbra, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 3, 2022 PR Newswire ALAMEDA, Calif. , Oct. 6, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss fina...

The shares of medical device maker Penumbra, Inc. ( NYSE: PEN ) dropped Wednesday after Citi downgraded the company to Neutral from Buy, citing, among other things, the stock's recent outperformance despite macro concerns. The analyst Joanne Wuensch notes that PEN rallied ...

Summary Asian markets continue to struggle this year, thanks in large part to the weak China market. The only asset class showing positive performance is volatility. It has been a bumpy ride down this year, with six failed rally attempts. We are now 25.3% below the high water mark...

Penumbra ( NYSE: PEN ) is collaborating with Japan's Asahi Intecc to bring the Alameda, Calif.-based company's Indigo Aspiration System to the Japanese market upon regulatory approval. Indigo is a minimally-invasive device which can be used to remove emboli a...

Companies aim to introduce Penumbra’s most advanced peripheral mechanical thrombectomy technology to Japan upon regulatory approval Lightning technology is designed for single session blood clot removal in peripheral arterial and venous systems, including for diseases such ...

Needham raised its recommendation on Penumbra, Inc. ( NYSE: PEN ) on Friday to Buy from Hold, citing a faster growth trajectory for the California-based medical device maker based on management remarks. The analysts led by Mike Matson point to PEN’s management as no...

Penumbra ( NYSE: PEN ) on Wednesday said it had got the European Commission's CE Mark for its RED Reperfusion Catheters product and that the catheters were now commercially available in Europe. Shares of the Alameda, Calif.-based medical device company gained 11.4% ...

Physicians in Europe now have access to Penumbra’s latest stroke technology for mechanical thrombectomy RED ® reperfusion catheters are designed with optimized trackability and aspiration efficiency to help navigate the complex anatomy of the brain and deliver powe...

Initial INSIGHT Registry data demonstrated RED ® reperfusion catheters were highly effective in removing all clot types with an impressive 68.9% mTICI > 2b-3 overall first pass effect rate COMPLETE study sub-analyses of tandem lesions and late window showed aspirat...

Penumbra, Inc. to Present at Upcoming Investor Conferences PR Newswire ALAMEDA, Calif. , Aug. 24, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the...